Abbott reported third-quarter revenue growth of 15% year over year, boosted by the addition of Exact Sciences. Reported earnings fell 44% due to increased amortization, legal settlements, and acquisition costs. Abbott also indicated the nutrition business will be spun off in late 2027.
Abbott has been investing in structural heart products, including the left atrial appendage closure and transcatheter mitral valve markets.
Edwards Lifesciences' Pascal device and its emerging portfolio of transcatheter mitral technologies are likely to put pressure on Abbott's MitraClip franchise over the longer term.
|
Metric
|
ABT
|
RHHBY
|
MDT
|
|---|---|---|---|
Price/Earnings (Normalized) | 24.28 | 20.73 | 16.75 |
Price/Book Value | 3.55 | 9.45 | 2.42 |
Price/Sales | 3.79 | 4.87 | 3.25 |
Price/Cash Flow | 16.75 | 15.25 | 13.60 |
|
Metric
|
ABT
|
RHHBY
|
MDT
|
|---|---|---|---|
Quick Ratio | 0.97 | 0.80 | 1.29 |
Current Ratio | 1.38 | 1.23 | 2.07 |
Interest Coverage | 10.40 | 13.49 | 10.12 |
|
Metric
|
ABT
|
RHHBY
|
MDT
|
|---|---|---|---|
Return on Assets (Normalized) | — | 15.81% | 8.31% |
Return on Equity (Normalized) | — | 48.77% | 15.59% |
Return on Invested Capital (Normalized) | — | 23.90% | 10.57% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Medtronic PLC
MDT
| LOCK|D!tCXw | LOCK|%%X>D | $121B | |||
| Stryker Corp
SYK
| LOCK|&LJfTj> | LOCK|^B | $117B | |||
| Boston Scientific Corp
BSX
| LOCK|n&%hdh& | LOCK|S$s& | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|pd&D<l> | LOCK|?$@w | $52B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|c<Lm?@W | LOCK|dZr | $33B | |||
| DexCom Inc
DXCM
| LOCK|^@?Tp?w? | LOCK|CkF> | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|C& | LOCK|>?W | $26B | |||
| Steris PLC
STE
| LOCK|gsXjt< | LOCK|%?<h | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|wgsTl>j | LOCK|p>Q | $19B |
United States